G-BA decisons from 20July 2023
Here are the G-BA decisions from the G-BA meeting held on 20 July 2023 on the early benefit assessments of Enhertu, Imbruvica,
Category: News and updates
G-BA decisions from 12 May 2023
Here are the G-BA decisions from the G-BA meeting held on 12 May 2023 on the early benefit assessments of Tezpire, Adtralza
G-BA decisions from 20 April 2023
Here are the G-BA decisions from the G-BA meeting held on 20 April 2023 on the early benefit assessments of Ultomiris, Genvoya,
The German Ministry of Health introduces new “flat day rates” for hospital day treatments
At the end of September 2022, the hospital commission suggested introducing flat day rates (German: “Tagespauschalen”) for hospital day treatments. Driven by
G-BA requested RWE collection for the second time – Fedratinib in myelofibrosis
Since 2020, the G-BA can request real-world evidence data collection in Germany. However, so far this was only implemented for one product,